ProMetic Life Sciences Inc.: Results Of Pathogen Removal and Diagnostic Technologies Inc.'s Brain Spike Study Published In Transfusion

Pathogen Removal and Diagnostic Technologies Inc. ("PRDT"), and its co-development, commercial and manufacturing partner MacoPharma SA ("MacoPharma") announced that Transfusion, the American Association of Blood Banks' monthly peer-reviewed journal and a leading scientific publication in the field of blood transfusion medicine, published in its July issue the results of an extensive study sponsored by PRDT. PRDT is a joint venture between ProMetic Life Sciences Inc. (TSX: PLI) and the American Red Cross.